Related Articles
Proton pump inhibitors and risk of gastrointestinal cancer: A meta‑analysis of cohort studies
Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
Antiplatelet therapy with or without PPIs for the secondary prevention of cardiovascular diseases in patients at high risk of upper gastrointestinal bleeding: A systematic review and meta-analysis
Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors
Proton pump inhibitors decrease melanogenesis in melanocytes